BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37494434)

  • 1. Multi-tiered approach to detect autoimmune cross-reactivity of therapeutic T cell receptors.
    Ishii K; Davies JS; Sinkoe AL; Nguyen KA; Norberg SM; McIntosh CP; Kadakia T; Serna C; Rae Z; Kelly MC; Hinrichs CS
    Sci Adv; 2023 Jul; 9(30):eadg9845. PubMed ID: 37494434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.
    Gee MH; Sibener LV; Birnbaum ME; Jude KM; Yang X; Fernandes RA; Mendoza JL; Glassman CR; Garcia KC
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7369-E7378. PubMed ID: 30021852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs.
    Bijen HM; van der Steen DM; Hagedoorn RS; Wouters AK; Wooldridge L; Falkenburg JHF; Heemskerk MHM
    Mol Ther; 2018 May; 26(5):1206-1214. PubMed ID: 29567312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
    Ochi T; Nakatsugawa M; Chamoto K; Tanaka S; Yamashita Y; Guo T; Fujiwara H; Yasukawa M; Butler MO; Hirano N
    Cancer Immunol Res; 2015 Sep; 3(9):1070-81. PubMed ID: 25943533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell Receptors Engineered
    Sharma P; Harris DT; Stone JD; Kranz DM
    Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPU-Accelerated Discovery of Pathogen-Derived Molecular Mimics of a T-Cell Insulin Epitope.
    Whalley T; Dolton G; Brown PE; Wall A; Wooldridge L; van den Berg H; Fuller A; Hopkins JR; Crowther MD; Attaf M; Knight RR; Cole DK; Peakman M; Sewell AK; Szomolay B
    Front Immunol; 2020; 11():296. PubMed ID: 32184781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.
    Soon CF; Zhang S; Suneetha PV; Antunes DA; Manns MP; Raha S; Schultze-Florey C; Prinz I; Wedemeyer H; Sällberg Chen M; Cornberg M
    Front Immunol; 2019; 10():2076. PubMed ID: 31552033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy.
    Donermeyer DL; Weber KS; Kranz DM; Allen PM
    J Immunol; 2006 Nov; 177(10):6911-9. PubMed ID: 17082606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast Display for the Identification of Peptide-MHC Ligands of Immune Receptors.
    Huisman BD; Grace BE; Holec PV; Birnbaum ME
    Methods Mol Biol; 2022; 2491():263-291. PubMed ID: 35482196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes.
    Duong MN; Erdes E; Hebeisen M; Rufer N
    J Immunother Cancer; 2019 Nov; 7(1):284. PubMed ID: 31690351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy.
    Simister PC; Border EC; Vieira JF; Pumphrey NJ
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35851311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.
    Dunn SM; Rizkallah PJ; Baston E; Mahon T; Cameron B; Moysey R; Gao F; Sami M; Boulter J; Li Y; Jakobsen BK
    Protein Sci; 2006 Apr; 15(4):710-21. PubMed ID: 16600963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs.
    Uemura Y; Senju S; Maenaka K; Iwai LK; Fujii S; Tabata H; Tsukamoto H; Hirata S; Chen YZ; Nishimura Y
    J Immunol; 2003 Jan; 170(2):947-60. PubMed ID: 12517961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deconstructing the peptide-MHC specificity of T cell recognition.
    Birnbaum ME; Mendoza JL; Sethi DK; Dong S; Glanville J; Dobbins J; Ozkan E; Davis MM; Wucherpfennig KW; Garcia KC
    Cell; 2014 May; 157(5):1073-87. PubMed ID: 24855945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit.
    Luo X; Cui H; Cai L; Zhu W; Yang WC; Patrick M; Zhu S; Huang J; Yao X; Yao Y; He Y; Ji Y
    Front Immunol; 2020; 11():623. PubMed ID: 32425926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
    Baumgaertner P; Schmidt J; Costa-Nunes CM; Bordry N; Guillaume P; Luescher I; Speiser DE; Rufer N; Hebeisen M
    Front Immunol; 2022; 13():973986. PubMed ID: 36032094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity.
    Vazquez-Lombardi R; Jung JS; Schlatter FS; Mei A; Mantuano NR; Bieberich F; Hong KL; Kucharczyk J; Kapetanovic E; Aznauryan E; Weber CR; Zippelius A; Läubli H; Reddy ST
    Immunity; 2022 Oct; 55(10):1953-1966.e10. PubMed ID: 36174557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy.
    Plewa N; Poncette L; Blankenstein T
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.
    Hellman LM; Foley KC; Singh NK; Alonso JA; Riley TP; Devlin JR; Ayres CM; Keller GLJ; Zhang Y; Vander Kooi CW; Nishimura MI; Baker BM
    Mol Ther; 2019 Feb; 27(2):300-313. PubMed ID: 30617019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.